Home Amines 942-70-1
942-70-1,MFCD00981219
Catalog No.:AA006CMS

942-70-1 | 5-(4-Fluorophenyl)-1,3,4-thiadiazol-2-amine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
95%
in stock  
$56.00   $39.00
- +
1g
96%
in stock  
$70.00   $49.00
- +
5g
96%
in stock  
$185.00   $130.00
- +
25g
96%
in stock  
$710.00   $497.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA006CMS
Chemical Name:
5-(4-Fluorophenyl)-1,3,4-thiadiazol-2-amine
CAS Number:
942-70-1
Molecular Formula:
C8H6FN3S
Molecular Weight:
195.2167
MDL Number:
MFCD00981219
SMILES:
Fc1ccc(cc1)c1nnc(s1)N
Properties
Properties
 
Form:
Solid  
MP:
238-243 °C  

Computed Properties
 
Complexity:
173  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
1.8  

Downstream Synthesis Route

[1]Guan,Peng;Wang,Lei;Hou,Xuben;Wan,Yichao;Xu,Wenfang;Tang,Weiping;Fang,Hao[BioorganicandMedicinalChemistry,2014,vol.22,#21,p.5766-5775]

[2]Tu,GuoGang;Li,ShaoHua;Huang,HuiMing;Li,Gang;Xiong,Fang;Mai,Xi;Zhu,HuaWei;Kuang,BinHai;Xu,WenFang[BioorganicandMedicinalChemistry,2008,vol.16,#14,p.6663-6668]

[3]Ramprasad,Jurupula;Nayak,Nagabhushana;Dalimba,Udayakumar;Yogeeswari,Perumal;Sriram,Dharmarajan;Peethambar;Achur,Rajeshwara;Kumar,H.S.Santosh[EuropeanJournalofMedicinalChemistry,2015,vol.95,p.49-63]

[4]Ramprasad,Jurupula;Nayak,Nagabhushana;Dalimba,Udayakumar[EuropeanJournalofMedicinalChemistry,2015,vol.106,p.75-84]

[5]CurrentPatentAssignee:NANCHANGUNIVERSITY-CN108148017,2018,ALocationinpatent:Paragraph0035;0036

[6]Locationinpatent:experimentalpartAlegaon,ShankarG.;Alagawadi,KallanagoudaR.[MedicinalChemistryResearch,2012,vol.21,#6,p.816-824]

[7]CurrentPatentAssignee:KOREARESEARCHINSTITUTEOFCHEMICALTECHNOLOGY-EP3892622,2021,A1Locationinpatent:Paragraph0281-0285

[8]Foroumadi;Tabatabai;Gitinezhad;Zarrindast;Shafiee[PharmacyandPharmacologyCommunications,2000,vol.6,#1,p.31-33]

[9]Locationinpatent:experimentalpartWang,Peng;Wan,Rong;Han,Fen;Wang,Yao[JournalofChemicalResearch,2009,#11,p.671-673]

[10]Locationinpatent:experimentalpartWan,Rong;Wang,Peng;Han,Fen;Wang,Yao;Zhang,Jianqiang[SyntheticCommunications,2011,vol.41,#6,p.864-870]

[11]Locationinpatent:experimentalpartHu,Jun;Sun,Jianguang;Zhou,Taoyu;Xu,Yanhua[JournalofChemicalResearch,2011,vol.35,#8,p.442-443]

[12]Locationinpatent:experimentalpartYang,Xian-Hui;Xiang,Lu;Li,Xi;Zhao,Ting-Ting;Zhang,Hui;Zhou,Wen-Ping;Wang,Xiao-Ming;Gong,Hai-Bin;Zhu,Hai-Liang[BioorganicandMedicinalChemistry,2012,vol.20,#9,p.2789-2795]

[13]Locationinpatent:experimentalpartZhao,Zhigang;Li,Lin;Liu,Min;Mei,Qinggang[JournalofChemicalResearch,2012,vol.36,#4,p.218-221]

[14]Xue,Xiao-Jian;Wang,Yu-Bin;Lu,Peng;Shang,Hai-Feng;She,Jin-Xiong;Xia,Ling-Xian;Qian,Hai;Huang,Wen-Long[ChemicalandPharmaceuticalBulletin,2014,vol.62,#6,p.524-527]

[15]Gao,Min;He,Junhua;Xu,Weidong;Lai,Xiaoping;Liu,Fen;Tu,Guogang[Pharmazie,2018,vol.73,#3,p.123-127]

[16]Mali,JaishreeK.;Sutar,YogeshB.;Pahelkar,AkshataR.;Verma,PreetiM.;Telvekar,VikasN.[ChemicalBiologyandDrugDesign,2020,vol.95,#1,p.174-181]

[17]Barreca,MariaLetizia;Bojarski,AndrzejJ.;Cecchetti,Violetta;Cook,GregoryM.;Desantis,Jenny;Felicetti,Tommaso;Franzblau,ScottG.;Handzlik,Jadwiga;Hards,Kiel;Latacz,Gniewomir;Manfroni,Giuseppe;Massari,Serena;Mazzarella,MariaAngela;Nakatani,Yoshio;Nizi,MariaGiulia;Rushton-Green,Rowena;Sabatini,Stefano;Shetye,Gauri;Tabarrini,Oriana;Kolář,MichalH.;Satała,Grzegorz[EuropeanJournalofMedicinalChemistry,2020,vol.201]

[1]Patent:WO2008/70707,2008,A1.Locationinpatent:Page/Pagecolumn9-10

[1]Locationinpatent:experimentalpartLi,Shao-Hua;Li,Gang;Huang,Hui-Ming;Xiong,Fang;Mai,Xi;Kuang,Bin-Hai;Liu,Cheng-Mei;Tu,Guo-Gang[Pharmazie,2009,vol.64,#2,p.67-70]

[1]BioorganicandMedicinalChemistryLetters,2011,vol.21,p.5735-5738

C16H15FN3O3PolS 
  942-70-1    7659-07-6 

[1]ACSCombinatorialScience,2015,vol.17,p.732-741

Literature

Title: 2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase.

Journal: European journal of medicinal chemistry 20131101

Title: 5-(3-Fluoro-phen-yl)-1,3,4-thia-diazol-2-amine.

Journal: Acta crystallographica. Section E, Structure reports online 20090601

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:942-70-1 Molecular Formula|942-70-1 MDL|942-70-1 SMILES|942-70-1 5-(4-Fluorophenyl)-1,3,4-thiadiazol-2-amine |Halogenated_Heterocycles